Folicil

Quick links to important sections

Folicil

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folicil

What is Folicil?

Folicil is a medicinal product containing folic acid, which is a synthetic form of folate, a water-soluble B-vitamin. Folate is an essential nutrient that the human body requires for several fundamental biological processes, including the synthesis of nucleic acids and the metabolism of amino acids.

Composition and Role

The active ingredient in Folicil, folic acid, serves as a precursor to tetrahydrofolate. This compound acts as a coenzyme in various metabolic reactions. It is particularly critical for DNA replication and the maintenance of genetic integrity. Because the human body cannot synthesize folate de novo, it must be obtained through dietary sources or supplementation.

Biological Importance

Folate plays a vital role in the production and maturation of red blood cells. It is also deeply involved in cellular division and growth, making it especially important during periods of rapid cell proliferation.

In the context of fetal development, adequate folate levels are necessary for the proper formation of the neural tube, which eventually develops into the brain and spinal cord. Furthermore, folic acid is involved in the conversion of homocysteine to methionine; maintaining balanced levels of these amino acids is an important aspect of cardiovascular and systemic health.

Regulatory References

  1. NIH Office of Dietary Supplements Fact Sheet
  2. WHO Essential Medicines List Entry
  3. WHO Essential Medicines List

What side effects are possible with Folicil?

Folicil, containing Folic Acid, is generally considered to have a favorable safety profile. Adverse reactions documented in official regulatory sources are typically rare and may affect several body systems.

Documented Adverse Reactions

The most significant and serious documented adverse effects relate to the Immune System. Regulatory labels classify anaphylactic reactions (including shock) and severe hypersensitivity reactions (such as bronchospasm and respiratory difficulty) as rare events. Other less frequent adverse reactions may be reported, often at higher daily doses, and are officially grouped into system-organ classes:

  • Gastrointestinal Disorders: Reports of anorexia, nausea, abdominal distension, and flatulence.
  • Nervous System Effects: Reported effects include altered sleep patterns, irritability, confusion, and impaired judgment.

Safety-Related Restrictions and Considerations

The safety profile includes critical limitations and warnings that are not related to side effect frequency but to diagnostic considerations.

Masking of Pernicious Anemia: A primary safety restriction is that Folic Acid, particularly in doses exceeding 0.1 mg daily, may obscure the diagnosis of pernicious anemia (Vitamin B12 deficiency). By correcting the blood indicators of the deficiency, Folicil may allow the associated neurologic complications to worsen or progress undetected.

Concomitant Medication Safety: Caution is noted in patients taking certain antiepileptic medications (such as phenytoin). Regulatory documents indicate that Folic Acid may potentially increase the incidence of seizures in this population.

Use in Specific Populations: Official regulatory documents state that there are no known hazards to the use of Folic Acid during pregnancy or lactation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Folicil (Folic Acid) indicates a low acute and chronic toxicity risk, with no specific antidote known. Management is generally limited to symptomatic and supportive treatment when necessary.


Documented Overdose Manifestations

Symptoms associated with very high long-term doses are typically non-severe. Regulatory documents list gastrointestinal disturbances (e.g., nausea, abdominal distension) and Central Nervous System (CNS) effects (e.g., altered sleep patterns, irritability, confusion) as possible manifestations. Rare instances of allergic manifestations, including severe reactions like anaphylaxis, have also been reported.


When to Seek Urgent Medical Attention

Official labeling mandates that individuals must seek immediate medical attention and contact emergency services or a Poison Control Center if an overdose is suspected or if unexpected severe symptoms occur.


Critical Regulatory Warning

The most critical regulatory constraint regarding high intake is the potential to mask the hematologic symptoms of an underlying Vitamin B12 deficiency, allowing the associated neurological complications to progress irreversibly. This is a primary consideration in the evaluation and management of high-dose exposure.

Therapeutic Uses of Folicil

What Folicil Treats: Main Uses and Benefits

Folicil is used to address or help prevent conditions associated with its deficiency, supporting essential processes within the body. The primary application involves the management of specific types of anemia, particularly megaloblastic anemia, which can cause symptoms such as fatigue and generalized weakness. By aiding in the production and maturation of red blood cells, Folicil assists in maintaining normal blood health.

It is also commonly administered to support health during periods of increased physiological demand, most notably during pregnancy. This use is intended to help manage the risk of specific birth outcomes related to deficiency. Clinical scenarios where Folicil may be recommended include nutritional deficiencies, malabsorption syndromes, and conditions where certain medications increase the body's need for this substance. The application of this supplement is consistent with established clinical practice regarding its utility.

Quick Fact

Relief for Megaloblastic Anemia Folicil helps in the recovery of normal red blood cell production in patients experiencing megaloblastic anemia due to deficiency.

Eligibility and Restrictions for Use

Who can and cannot use Folicil?

The population eligibility for Folicil (Folic Acid) is defined by mandatory restrictions and allowed use across various groups, as documented in regulatory information.

Eligibility Classification Population Group/Condition
Absolute Contraindication Untreated Cobalamin (Vitamin B12) deficiency, including pernicious anemia.
Absolute Contraindication Hypersensitivity to Folic Acid or any formulation excipients.
Restricted Use/Caution Patients with potential folate-dependent tumours.
Restricted Use/Caution Undiagnosed megaloblastic anemia (must not be used as monotherapy).
Generally Permitted Adults, the elderly, and the pediatric population (ge 1 year).
Generally Permitted Pregnant women and women capable of conceiving.
Generally Permitted Lactating women, as no adverse effects have been observed in breastfed infants.

Regulatory documents explicitly state that Folicil must not be administered alone for anemia caused by Vitamin B12 deficiency, as this may mask the condition while allowing neurological damage to progress. The medicine is broadly permitted for labeled indications in most age groups and is acceptable for use during pregnancy and breastfeeding. Special caution is advised for patients with malignant disease unless the megaloblastic anemia is confirmed to be folate-related.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Folicil (Folic Acid / Vitamin B9) interactions are officially documented as pharmacodynamic antagonism and pharmacokinetic effects on co-administered medicines.


Documented Pharmacological Interactions

Interaction Type Interacting Substances (Official Labeling)
Pharmacodynamic Antagonism Anti-Folate Agents: Methotrexate, Pyrimethamine, Trimethoprim, and Sulfonamides. Co-administration may reduce the therapeutic effect of the anti-folate medicine.
Reduced Drug Exposure Anticonvulsants: Phenytoin, Phenobarbital, Primidone, and Carbamazepine. Folicil is documented to lower the plasma concentration of these medicines, which may compromise seizure control.

Interaction-Related Restrictions and Conditions

The use of Folicil in doses above 1 mg per day is contraindicated in patients with undiagnosed megaloblastic anemia. This restriction exists because Folicil can mask the hematologic symptoms of Vitamin B12 deficiency, potentially allowing irreversible neurological damage to progress.

Absorption interference is documented with certain antacids (containing aluminium or magnesium). Regulatory guidance states that Folicil administration should be separated by at least two hours from these antacids to ensure proper Folicil absorption. Chronic or excessive alcohol consumption is also noted to decrease Folicil absorption and increase its elimination, potentially leading to a deficiency state.

Mechanism of Action

Enzyme-Dependent Activation of the Coenzyme

Folicil, which supplies Folic Acid, is metabolically inactive until it undergoes enzymatic reduction by Dihydrofolate Reductase (DHFR) into Tetrahydrofolate (THF). This initial molecular action establishes the necessary coenzyme availability, as THF functions as the universal carrier of one-carbon units required for all downstream biological processes.


Direct Requirement for DNA and Cellular Replication

The resulting THF coenzyme is critical for the de novo synthesis of purine and thymidylate bases, which are the fundamental building blocks of DNA. This action is required for the high rate of accurate cell division (mitosis) in rapidly proliferating cells, such as the erythroid stem cells in the bone marrow. The physiological consequence is the production of normally maturing cells, a function related to the failure of cellular division known as megaloblastosis.


Modulation of Metabolic Cycles

Folate derivatives are integral to the methionine cycle, where they assist the enzyme Methionine Synthase in converting circulating homocysteine into methionine. This pathway modulation is required for generating crucial methyl donors utilized in various biosynthetic reactions, contributing to the status of multiple cell systems.

Dosage and Administration Information

How to Use Folicil

The usage of Folicil (Folic Acid) is defined by administration guidelines that detail the appropriate route, dosage, frequency, and contextual conditions for intake.


Administration Scope

Category Description
Route of administration: Oral administration, typically as a tablet, is the preferred method. Parenteral routes (IV, IM, SC) are reserved for patients with severe intestinal malabsorption or those unable to take the medicine by mouth, and require administration by a healthcare provider.
Dosing schedule: The standard therapeutic dose for adults generally ranges from 1 mg once daily up to 5 mg once daily for initial treatment. Doses may be increased up to 15 mg daily in cases of severe malabsorption.
Frequency and timing: The medication is typically administered once daily. Tablets should be taken with water and may be consumed independent of meals. Administration must be separated from certain other medications, such as antacids or Cholestyramine, by specific time intervals to ensure proper absorption.
Course duration / cycle information: Initial therapeutic courses for deficiency often last approximately four months or continue until blood parameters have normalized. Prophylaxis for high-risk conditions, such as neural tube defects, is maintained with a daily dose throughout the first trimester of pregnancy.
Missed-dose rules: If a dose is forgotten, the standard protocol is to skip the missed dose and continue with the next scheduled dose; a double dose should not be taken to compensate.

Connection to the overall use protocol

The instructions establish the standardized approach by prioritizing the oral route and defining specific daily dose ranges that account for the severity of the condition. They define a consistent schedule and the therapeutic duration, such as the initial four-month course. These details govern the logistics of Folicil administration in clinical practice.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes research that has explored the potential influence of the combination drug on symptoms associated with the common cold. The information below is descriptive of study findings and is not a substitute for professional medical advice.


Overview of Research Scope

Research has explored the potential impact on symptom duration and severity among common cold symptoms. Studies typically focus on the combined effect of the active ingredients, with measured outcomes including symptom scores and time to symptom resolution.

  • One large-scale trial observed a decrease in the overall symptom load score among patients who began treatment within 24 hours of symptom onset.
  • The study used a defined scale to measure the total burden of symptoms, including fever, cough, and sore throat.
  • The trials evaluated a duration of 7 days. Study outcomes were measured following the completion of the evaluated treatment period.

Specific Symptom Evaluation

Other studies also investigated whether the study interventions were associated with a change in headache and nasal congestion, and examined the time point when participants first reported a change related to body aches. Findings from these smaller trials suggest that participants reported a change in these symptoms during the study period.

  • Research has evaluated the component ingredients compared to single-ingredient remedies, and noted that the formulation addresses multiple symptoms.
  • Studies have not yet fully clarified whether the combination is associated with an earlier return to daily activities compared to placebo.

--ôs

Safety and Patient Groups

Trial data generally excluded participants also using X. Trial data has indicated a potential association between the study drug and reports of severe dizziness.

  • Trial populations have primarily included healthy adults aged 18–65. Evidence remains limited regarding the outcomes for adolescents or adults over 65.
  • Current research has not directly assessed the outcomes in patients with pre-existing kidney or liver conditions.

Frequently Asked Questions (FAQ)

Common questions about Folicil (FAQ)


Q: Is Folicil the same thing as regular folic acid?

Folicil is described in official documents as supplying Folic Acid, which is the chemical name for the active ingredient. Folic Acid is generally considered the synthetic, highly stable form of the vitamin, while 'folate' is the generic name for the vitamin group found naturally in foods.


Q: How quickly can someone expect to see results from Folicil?

Folic Acid is absorbed rapidly into the bloodstream from the small intestine after it is taken orally. Official pharmacological data indicates that peak levels in the plasma (blood) are usually reached within approximately one hour after a dose.


Q: What happens if I miss taking Folicil one day?

Regulatory guidance on missed doses is to continue with the next scheduled dose as planned. Taking a double dose to compensate for a missed one is advised against in official documents.


Q: Does Folicil affect mood or mental clarity?

Official reports of adverse reactions, particularly when higher daily doses are used, include some effects on the nervous system. These documented effects may involve reports of altered sleep patterns, irritability, difficulty in concentrating, and confusion.


Q: Is Folicil available over-the-counter or does it require a prescription?

Folic Acid is available in some lower amounts as an over-the-counter supplement. However, the higher, therapeutic doses described in official drug labeling for treating deficiencies are typically supplied as prescription-only medicines.


Q: Can lifestyle factors like smoking or alcohol affect Folicil's effectiveness?

Regulatory documents and patient information note that chronic alcohol consumption, especially in conditions like alcoholic cirrhosis, may interfere with Folic Acid's metabolism. This interference is noted as potentially leading to reduced absorption or elimination, which may impact folate status.


Q: How is Folicil generally processed by the body?

According to official clinical pharmacology information, Folic Acid is quickly absorbed, primarily through the digestive system. It is then rapidly converted by the liver into an active form the body can utilize for its essential metabolic functions.


Q: Is Folicil meant to be taken long-term or short-term?

The required duration of use is defined by the specific condition being addressed. While initial treatment for deficiency may last several months, use for high-risk prevention (prophylaxis) in certain situations may be long-term.


Q: Can men use Folicil for any reason?

Folic Acid is effective in addressing megaloblastic anemia and deficiency states that can affect adults of all genders. Official sources confirm the necessity of Folic Acid for key metabolic processes in the human body.


Q: Where can I find official, non-commercial patient information about Folicil?

Official, non-commercial patient information can be accessed directly through government drug databases. These sources include the DailyMed database in the United States and the Summary of Product Characteristics (SmPC) from the European Medicines Agency.


Q: Does Folicil have any known interactions with herbal supplements?

Official guidance indicates that caution is noted regarding combining Folic Acid with herbal supplements. Some documents specifically note that Folic Acid may reduce the action of supplements that contain the mineral zinc.


Q: Can taking Folicil affect the results of common blood tests?

Taking Folic Acid supplements may affect the results of laboratory tests used to measure folate levels in the blood. Regulatory documents also indicate that some other medicines, like certain antibiotics, can cause misleading results for these levels.


Q: What kind of evidence is Folicil's approval based on?

Folic Acid is recognized globally and is included on the World Health Organization’s Essential Medicines List. Its regulatory approval is based on well-established evidence demonstrating its vital role in addressing and preventing specific types of anemia and nutritional deficiencies.


Q: Are there different strengths or forms of Folicil available?

Official product information shows that Folic Acid is available in several different strengths and various physical forms, including oral tablets, capsules, and solutions intended for injection.


Q: What is the difference between an 'interaction' and a 'side effect' for Folicil?

A drug interaction is when Folicil alters the effects of another medicine or substance that is co-administered. A side effect, by contrast, is an unwanted physical effect that is caused by Folicil itself, such as a documented rash or gastrointestinal upset.


Q: Is it safe to drive or operate machinery while using Folicil?

Official regulatory documents from Europe state that Folic Acid is not known to have effects on the ability to drive or operate machinery.


Q: Can Folicil be used by children, according to regulatory sources?

According to official documentation, Folic Acid is indicated for addressing megaloblastic anemia of infancy and can generally be used in the pediatric population (e.g., children aged one year and older) when prescribed for an approved indication.


Q: What should be done if someone accidentally takes too much Folicil?

While Folic Acid is considered non-toxic to humans in typically prescribed amounts, official guidance notes that medical advice should be sought in the event of a suspected accidental excessive intake.


Q: Is Folicil manufactured by many different companies?

As Folic Acid is an established active ingredient whose patent has expired, it is widely available. Regulatory agencies have approved its manufacture and distribution as a generic product from numerous different companies.


Q: What are the ingredients in Folicil that might cause an allergic reaction?

Official product labels specify that an allergic reaction can be caused by the active component, Folic Acid, or by any of the inactive ingredients, which are known as excipients. These excipients can include substances like lactose monohydrate or various stabilizers.


Q: How is Folicil different from folate found naturally in foods?

Folicil provides Folic Acid, which is the synthetic form of the vitamin and is known to be more chemically stable. Natural folates found in food sources are generally more susceptible to degradation from heat, cooking, or prolonged storage.


Q: Why do some people feel no effect from Folicil?

Official medical literature acknowledges that the body's systems for absorbing and processing Folic Acid can be complex. These biological complexities may contribute to variable patient responses observed after administration.


Q: Do experts view Folicil as a long-term therapeutic option?

Official documentation confirms that Folic Acid is essential and is used for long-term prevention in specific high-risk situations. However, regulatory documents indicate that long-term use is associated with the need for monitoring due to the risk of masking a Vitamin B12 deficiency.


Q: Is there a generic version of Folicil available?

As Folic Acid is the non-proprietary chemical name for the active ingredient, the medicine is widely available as a generic product. Regulatory bodies have approved multiple generic formulations from various manufacturers.

How should Folicil be stored and disposed of?

How to Store and Dispose of Folicil?

Storage of Folicil (Folic Acid tablets) must strictly adhere to regulatory standards to ensure product stability.

Official Storage Conditions

Folicil must be stored at Controlled Room Temperature, which ranges from 20°C to 25°C (68°F to 77°F). The medicine must be protected from moisture and kept in its original container, with the lid tightly closed. As a mandatory safety requirement, the product must be stored out of the reach of children.

Storage Requirement Official Guidance
Temperature Controlled Room Temperature (20 C to 25 C)
Container Store in original container; keep tightly closed
Protection Protect from moisture

Disposal Requirements

Disposal of any unused or expired Folicil must follow local regulations. The product should not be disposed of in household trash or wastewater unless specifically instructed by an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folicil found in:

A-Z Index: